6y5l Citations

Structural transitions in influenza haemagglutinin at membrane fusion pH.

OpenAccess logo Nature 583 150-153 (2020)
Related entries: 6y5g, 6y5h, 6y5i, 6y5j, 6y5k

Cited: 64 times
EuropePMC logo PMID: 32461688

Abstract

Infection by enveloped viruses involves fusion of their lipid envelopes with cellular membranes to release the viral genome into cells. For HIV, Ebola, influenza and numerous other viruses, envelope glycoproteins bind the infecting virion to cell-surface receptors and mediate membrane fusion. In the case of influenza, the receptor-binding glycoprotein is the haemagglutinin (HA), and following receptor-mediated uptake of the bound virus by endocytosis1, it is the HA that mediates fusion of the virus envelope with the membrane of the endosome2. Each subunit of the trimeric HA consists of two disulfide-linked polypeptides, HA1 and HA2. The larger, virus-membrane-distal, HA1 mediates receptor binding; the smaller, membrane-proximal, HA2 anchors HA in the envelope and contains the fusion peptide, a region that is directly involved in membrane interaction3. The low pH of endosomes activates fusion by facilitating irreversible conformational changes in the glycoprotein. The structures of the initial HA at neutral pH and the final HA at fusion pH have been investigated by electron microscopy4,5 and X-ray crystallography6-8. Here, to further study the process of fusion, we incubate HA for different times at pH 5.0 and directly image structural changes using single-particle cryo-electron microscopy. We describe three distinct, previously undescribed forms of HA, most notably a 150 Å-long triple-helical coil of HA2, which may bridge between the viral and endosomal membranes. Comparison of these structures reveals concerted conformational rearrangements through which the HA mediates membrane fusion.

Reviews - 6y5l mentioned but not cited (1)

  1. Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus. Borisevich SS, Zarubaev VV, Zarubaev VV, Shcherbakov DN, Yarovaya OI, Salakhutdinov NF. Viruses 15 902 (2023)

Articles - 6y5l mentioned but not cited (1)



Reviews citing this publication (19)

  1. Viral Membrane Fusion and the Transmembrane Domain. Barrett CT, Dutch RE. Viruses 12 E693 (2020)
  2. Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure. Wu NC, Wilson IA. Viruses 12 E1053 (2020)
  3. Influenza Neuraminidase Characteristics and Potential as a Vaccine Target. Creytens S, Pascha MN, Ballegeer M, Saelens X, de Haan CAM. Front Immunol 12 786617 (2021)
  4. Viral Membrane Fusion: A Dance Between Proteins and Lipids. White JM, Ward AE, Odongo L, Tamm LK. Annu Rev Virol 10 139-161 (2023)
  5. pH-Dependent Mechanisms of Influenza Infection Mediated by Hemagglutinin. Caffrey M, Lavie A. Front Mol Biosci 8 777095 (2021)
  6. Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: resolving the mechanisms with biophysical methods. Negi G, Sharma A, Dey M, Dhanawat G, Parveen N. Biophys Rev 14 1109-1140 (2022)
  7. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges. Terrier O, Si-Tahar M, Ducatez M, Chevalier C, Pizzorno A, Le Goffic R, Crépin T, Simon G, Naffakh N. PLoS Pathog 17 e1010106 (2021)
  8. Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses. Barre A, Van Damme EJM, Klonjkowski B, Simplicien M, Sudor J, Benoist H, Rougé P. Cells 11 339 (2022)
  9. Application of Super-Resolution and Advanced Quantitative Microscopy to the Spatio-Temporal Analysis of Influenza Virus Replication. Touizer E, Sieben C, Henriques R, Marsh M, Laine RF. Viruses 13 233 (2021)
  10. Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy. Tung Yep A, Takeuchi Y, Engelhardt OG, Hufton SE. Biomolecules 11 407 (2021)
  11. Stabilisation of Viral Membrane Fusion Proteins in Prefusion Conformation by Structure-Based Design for Structure Determination and Vaccine Development. Ebel H, Benecke T, Vollmer B. Viruses 14 1816 (2022)
  12. The ins and outs of virus trafficking through acidic Ca2+ stores. Gunaratne GS, Marchant JS. Cell Calcium 102 102528 (2022)
  13. pH-dependent endocytosis mechanisms for influenza A and SARS-coronavirus. Aganovic A. Front Microbiol 14 1190463 (2023)
  14. Invasion by exogenous RNA: cellular defense strategies and implications for RNA inference. Tang D, Liu Y, Wang C, Li L, Al-Farraj SA, Chen X, Yan Y. Mar Life Sci Technol 5 573-584 (2023)
  15. Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase. Jiang H, Zhang Z. Virol J 20 193 (2023)
  16. The Influenza A Virus Replication Cycle: A Comprehensive Review. Carter T, Iqbal M. Viruses 16 316 (2024)
  17. Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery. Zhao Y, Wang ZM, Song D, Chen M, Xu Q. Curr Opin Chem Biol 81 102499 (2024)
  18. Structural Framework for Analysis of CD4+ T-Cell Epitope Dominance in Viral Fusion Proteins. Landry SJ, Mettu RR, Kolls JK, Aberle JH, Norton E, Zwezdaryk K, Robinson J. Biochemistry 62 2517-2529 (2023)
  19. Visualizing intermediate stages of viral membrane fusion by cryo-electron tomography. Kephart SM, Hom N, Lee KK. Trends Biochem Sci 49 916-931 (2024)

Articles citing this publication (43)